Processing

Please wait...

Settings

Settings

1. WO1996002572 - ANTIGENIC POLYPEPTIDE SEQUENCE OF FACTOR VIII, FRAGMENTS AND/OR EPITOPES THEREOF

Publication Number WO/1996/002572
Publication Date 01.02.1996
International Application No. PCT/BE1995/000068
International Filing Date 14.07.1995
Chapter 2 Demand Filed 30.01.1996
IPC
A61K 38/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/755 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
745Blood coagulation or fibrinolysis factors
755Factors VIII
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/755
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
745Blood coagulation or fibrinolysis factors
755Factors VIII ; , e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Applicants
  • CROIX-ROUGE DE BELGIQUE [BE/BE]; Dépt. Central de Fractionnement Rue Joseph-Stallaert 5 B-1060 Bruxelles, BE (AllExceptUS)
  • LAUB, Ruth [BE/BE]; BE (UsOnly)
  • DI GIAMBATTISTA, Mario [BE/BE]; BE (UsOnly)
Inventors
  • LAUB, Ruth; BE
  • DI GIAMBATTISTA, Mario; BE
Agents
  • VAN MALDEREN, Eric ; Office Van Malderen Place Reine Fabiola 6/1 B-1080 Bruxelles, BE
  • VAN MALDEREN, Michel; Office Van Malderen Place Reine Fabiola 6/1 B-1080 Bruxelles, BE
Priority Data
940066614.07.1994BE
Publication Language French (FR)
Filing Language French (FR)
Designated States
Title
(EN) ANTIGENIC POLYPEPTIDE SEQUENCE OF FACTOR VIII, FRAGMENTS AND/OR EPITOPES THEREOF
(FR) SEQUENCE POLYPEPTIDIQUE ANTIGENIQUE DU FACTEUR VIII, FRAGMENTS ET/OU EPITOPES DE CELLE-CI
Abstract
(EN)
The present invention relates to an antigenic polypeptide sequence of factor VIII, comprised between the Glutamic Acid 1649 and Asparagine 2019, preferably comprised between Arginine 1652 and Arginine 1917 of the polypeptide sequence of factor VIII, or comprised between Alanine 108 and Methionine 355, or comprised between Aspartic Acid 403 and Aspartic Acid 725, or comprised between Lysine 2085 and Lysine 2249.
(FR)
La présente invention concerne une séquence polypeptidique antigénique du facteur VIII, comprise entre l'Acide Glutamique 1649 et l'Asparagine 2019, de préférence comprise entre l'Arginine 1652 et l'Arginine 1917 de la séquence polypeptidique du facteur VIII, ou comprise entre l'Alanine 108 et la Méthionine 355, ou comprise entre l'Acide Aspartique 403 et l'Acide Aspartique 725, ou comprise entre la Lysine 2085 et la Lysine 2249.
Also published as
Other related publications
Latest bibliographic data on file with the International Bureau